CareDx Launches AI Platform VANTx for Transplant Data Analysis

martes, 24 de marzo de 2026, 10:48 am ET1 min de lectura
CDNA--

CareDx launches AI-powered platform VANTx, analyzing complex transplant data and providing actionable clinical insights. Initially available via medical consultation, the platform will roll out to clinicians in 2026. BTIG raised its price target on CareDx from $25 to $26 while maintaining a Buy rating on the company's stock.

CareDx Launches AI Platform VANTx for Transplant Data Analysis

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios